Sentinel node biopsy – Pathological assessment

Recommendation

Sentinel node biopsy – Pathological assessment

In order to allow staging as per American Joint Committee on Cancer (AJCC) criteria, sentinel lymph nodes must be examined pathologically by a method which ensures detection of all clinically significant metastases (i.e. 2 mm or greater). All lymph node tissue should be processed. Immunohistochemistry can be used selectively. 

How this guidance was developed

This recommendation was based on the current American Joint Committee on Cancer (AJCC) Staging manual (eighth edition 2017). Although not developed as a clinical practice guideline, the AJCC Staging Manual was based on a comprehensive systematic review of the evidence. Because of the importance of this aspect of care and the strong evidentiary basis of the AJCC Staging Manual, it was agreed that this guidance should be a recommendation rather than a practice point. The guidance from the AJCC Staging Manual was simplified.

Sentinel node biopsy – Pathological assessment

Recommendation

In order to allow staging as per American Joint Committee on Cancer (AJCC) criteria, sentinel lymph nodes must be examined pathologically by a method which ensures detection of all clinically significant metastases (i.e. 2 mm or greater). All lymph node tissue should be processed. Immunohistochemistry can be used selectively. 

Principles in action
Image
Safe and quality care
Image
Care coordination

This recommendation was based on the current American Joint Committee on Cancer (AJCC) Staging manual (eighth edition 2017). Although not developed as a clinical practice guideline, the AJCC Staging Manual was based on a comprehensive systematic review of the evidence. Because of the importance of this aspect of care and the strong evidentiary basis of the AJCC Staging Manual, it was agreed that this guidance should be a recommendation rather than a practice point. The guidance from the AJCC Staging Manual was simplified.